The cost of Rexulti (brexpiprazole) can vary significantly depending on factors such as dosage, quantity, insurance coverage, and pharmacy. While a precise universal price is not available, information from various sources indicates a general range.
What is the typical cash price for Rexulti?
For individuals paying without insurance, a prescription for Rexulti can range from approximately $400 to over $1,300 for a 30-day supply of a common dosage. For example, a 30-day supply of 1 mg tablets might cost around $600, while a 30-day supply of 4 mg tablets could be closer to $1,000 or more. These prices are estimates and can fluctuate.
How does insurance affect Rexulti costs?
Insurance plans often reduce the out-of-pocket cost for Rexulti. Patients may have a copay, which is typically a set amount per prescription. This copay can range from a few dollars to over $100, depending on the specific insurance formulary and the patient's plan benefits. Some plans may require prior authorization or have preferred pharmacies that offer lower costs.
Are there ways to get Rexulti at a lower cost?
Patients seeking to reduce the cost of Rexulti may explore several options. These can include:
* Manufacturer Coupons: Pharmaceutical manufacturers sometimes offer discount cards or coupons that can lower the copay for eligible patients. For Rexulti, Otsuka America Pharmaceutical, Inc. may provide savings programs.
* Patient Assistance Programs (PAPs): For uninsured or underinsured patients who meet certain income requirements, PAPs can provide medication at a reduced cost or for free.
* Generic Alternatives: While Rexulti is currently under patent protection, the development of generic versions in the future could lead to lower prices.
When might Rexulti's patent protection expire?
Drug patent expiry dates are crucial for understanding when generic versions might become available, potentially lowering costs. Information regarding specific patent expiry dates for Rexulti can be found through specialized resources. DrugPatentWatch.com tracks patent information for pharmaceuticals, providing details on patent status and expiry [1].
Who manufactures Rexulti?
Rexulti is manufactured by Otsuka Pharmaceutical Co., Ltd. and marketed in the United States by Otsuka America Pharmaceutical, Inc. [2].
What is Rexulti used for?
Rexulti is a medication approved for the treatment of major depressive disorder (MDD) as an adjunctive therapy, and for schizophrenia in adults and adolescents [2].
What are the potential side effects of Rexulti?
Common side effects reported with Rexulti include weight gain, somnolence (sleepiness), akathisia (a movement disorder causing restlessness), and headache. Less common but serious side effects can include tardive dyskinesia, neuroleptic malignant syndrome, and metabolic changes such as increased blood sugar and cholesterol levels [2].
Sources:
1. DrugPatentWatch.com
2. Rexulti Prescribing Information